|
시장보고서
상품코드
2078006
스틸병 치료제 시장 : 치료제별, 투여 경로별, 유통 채널별, 지역별Stills Disease Treatment Market, By Treatment, By Route of Administration, By Distribution Channels and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) |
||||||
스틸병 치료제 시장은 2026년에 21억 1,000만 달러, 2033년까지 29억 7,000만 달러에 이를 것으로 예상되고 있습니다. 또한, 2026-2033년 CAGR 5.0%를 기록할 전망입니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준연도 | 2025년 | 시장 규모(2026년) | 21억 1,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR | 5.00% | 예측 금액(2033년) | 29억 7,000만 달러 |
스틸병(성인 발병형 스틸병(AOSD)이라고도 함)은 관절통, 발진, 발열을 특징으로 하는 희귀한 염증성 질환입니다. 이 중증 질환은 장기간에 걸친 만성 관절염이나 영구적인 장애를 유발할 가능성이 있습니다. 스틸병은 가려움증이 없는 발진과 고열을 동반합니다. 이 질환은 특히 손목 등 환부의 관절을 손상시킬 우려가 있습니다. 스틸병의 치료에는 항염증제가 사용됩니다. 스틸병은 희귀한 류마티스성 질환입니다. 이 질환은 고열, 관절 부종, 근육통, 인후통, 백혈구(특히 호중구) 증가, 생물학적 간염 등의 생물학적·임상적 증상을 특징으로 합니다. 스틸병의 치료는 대증요법과 근치요법 두 가지로 분류됩니다. 대증요법은 진단이 확정되지 않았더라도 즉시 시작할 수 있지만, 근치요법은 질병의 증상을 해소하기 위해 질환 자체를 보다 효과적으로 치료하는 것을 목적으로 합니다.
시장 역학
주요 기업들의 치료법 보급과 인수합병(M&A) 증가가 전 세계 스틸병 치료제 시장의 성장을 견인할 것으로 예측됩니다. 예를 들어, 2023년 4월 13일, 메트로폴리스 헬스케어는 비스테로이드성 항염증제(NSAID)를 이용한 스틸병 치료와 관련하여, 이러한 약물이 염증으로 인한 통증과 스틸병의 징후 및 증상을 완화한다고 지적했습니다. 코르티코스테로이드는 면역계의 활성을 저하시켜 염증을 억제합니다. 질병 수식 항류마티스 약물(DMARDs)은 스틸병의 진행을 늦추고 재발 빈도를 줄이는 데 도움이 됩니다. 물리치료, 운동, 휴식, 그리고 건강한 식단은 병세를 관리하고 증상을 최소화하는 데 도움이 됩니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 시장 성장 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 세계 스틸병 치료제 시장의 주요 기업 프로파일을 각종 지표(기업 개요, 제품 포트폴리오, 주요 동향, 재무 실적, 전략 등)를 바탕으로 수록했습니다.
- 본 보고서에서 다루고 있는 주요 기업으로는 AB2 Bio Ltd, F. Offmann-La Roche Ltd, Novartis AG, Swedish Orphan Biovitrum AB, Jubilant Life Sciences Ltd, Vintage Labs, Hikma Pharmaceuticals PLC, Teva Pharmaceutical Industries Ltd, Mylan N.V, Horizon Therapeutics plc, Sun Pharmaceutical Industries Ltd, Zydus Cadila, Amneal Pharmaceuticals LLC, Dr Reddy's Laboratories Ltd, Fresenius Kabi AG 등이 있습니다.
- 본 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계 스틸병 치료제 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 스틸병 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 스틸병 치료제 시장 : 치료제별(2021-2033년)
제5장 세계의 스틸병 치료제 시장 : 투여 경로별(2021-2033년)
제6장 세계의 스틸병 치료제 시장 : 유통 채널별(2021-2033년)
제7장 세계의 스틸병 치료제 시장 : 지역별(2021-2033년)
제8장 경쟁 구도
제9장 섹션
LSH 26.07.13Still's Disease Treatment Market is estimated to be valued at USD 2.11 Bn in 2026 and is expected to reach USD 2.97 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.11 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.00% | 2033 Value Projection: | USD 2.97 Bn |
Still's disease, also known as Adult-onset Still's Disease (AOSD), is a rare inflammatory disease characterized by joint pain, rash, and fever. This devastating condition can lead to long-term chronic arthritis and permanent injuries. Still's disease is associated with a rash that does not itch and a high fever. This disorder can destroy the affected joints, especially the wrists. Treatment for Still's disease includes anti-inflammatory medications. Still's disease is a rare rheumatic disease. This disease is characterized by biological and clinical symptoms such as high fever, joint swelling, myalgia, sore throat, increase in white blood cells (leukocytes, especially neutrophils), and biological hepatitis. Treatment for Still's disease can be divided into two categories, namely symptomatic treatments and effective treatments. Symptomatic treatment can be started immediately even if the diagnosis is not confirmed, while effective treatment methods are designed to treat the disease more effectively to eliminate the symptoms of the disease.
Market Dynamics
Increasing practices of treatments, mergers, and acquisitions by key market players are expected to drive the global Still's disease treatment market growth. For instance, on April 13, 2023, Metropolis Healthcare noted that treatment of Still's disease with nonsteroidal anti-inflammatory drugs (NSAIDs), these medications reduce inflammatory pain and the signs and symptoms of Still's disease. Corticosteroids reduce inflammation by reducing the activity of the immune system. Disease-modifying Antirheumatic Drugs (DMARDs) can help slow down the progress of Still's disease and reduce the frequency of flares. Physical therapy, exercise, rest, and a healthy diet can help manage the condition and keep symptoms to a minimum.
Key features of the study:
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global Still's disease treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include AB2 Bio Ltd , F.offmann-La Roche Ltd, Novartis AG, Swedish Orphan Biovitrum AB, Jubilant Life Sciences Ltd, Vintage Labs, Hikma Pharmaceuticals PLC, Teva Pharmaceutical Industries Ltd, Mylan N.V, Horizon Therapeutics plc, Sun Pharmaceutical Industries Ltd, Zydus Cadila, Amneal Pharmaceuticals LLC, Dr Reddy's Laboratories Ltd, and Fresenius Kabi AG
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global Still's disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Still's disease treatment market
Detailed Segmentation:
- Global Still's Disease Treatment Market, By Treatment :
- Pain Management
- Corticosteroids
- Tocilizumab
- Canakinumab
- Others
- Global Still's Disease Treatment Market, By Route of Administration (Revenue, USD Bn, 2021 - 2033)
- Injectables
- Oral
- Global Still's Disease Treatment Market, By Distribution Channels (Revenue, USD Bn, 2021 - 2033)
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Global Still's Disease Treatment Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- AB2 Bio Ltd.
- F.Hoffmann-La Roche Ltd
- Novartis AG
- Swedish Orphan Biovitrum AB
- Jubilant Life Sciences Ltd
- Vintage Labs
- Hikma Pharmaceuticals PLC
- Teva Pharmaceutical Industries Ltd
- Mylan N.V
- Horizon Therapeutics plc
- Sun Pharmaceutical Industries Ltd
- Zydus Cadila
- Amneal Pharmaceuticals LLC
- Dr Reddy's Laboratories Ltd
- Fresenius Kabi AG
"*" marked represents similar segmentation in other categories in the respective section
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Treatment
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Still's Disease Treatment Market, By Treatment, 2021-2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis,
- Segment Trends
- Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Tocilizumab
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Canakinumab
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
5. Global Still's Disease Treatment Market, By Route of Administration, 2021-2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Injectables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
6. Global Still's Disease Treatment Market, By Distribution Channel, 2021-2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Online Pharmacies
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
7. Global Still's Disease Treatment Market, By Region, 2021-2033, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021-2033, (US$ Billion)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- AB2 Bio Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F.Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Swedish Orphan Biovitrum AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Jubilant Life Sciences Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Vintage Labs
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Hikma Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teva Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mylan N.V
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Horizon Therapeutics plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sun Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Zydus Cadila
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amneal Pharmaceuticals LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Dr Reddy's Laboratories Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Fresenius Kabi AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
